Research ExplorerPublicationsBody mass index does not predict prostate-specific antigen o...

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

Standard

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. / Hutterer, Georg; Perrotte, Paul; Gallina, Andrea; Walz, Jochen; Jeldres, Claudio; Traumann, Miriam; Suardi, Nazareno; Saad, Fred; Bénard, François; Valiquette, Luc; McCormack, Michael; Graefen, Markus; Montorsi, Francesco; Karakiewicz, Pierre I.

In: EUR J CANCER, Vol. 43, No. 7, 7, 2007, p. 1180-1187.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Hutterer, G, Perrotte, P, Gallina, A, Walz, J, Jeldres, C, Traumann, M, Suardi, N, Saad, F, Bénard, F, Valiquette, L, McCormack, M, Graefen, M, Montorsi, F & Karakiewicz, PI 2007, 'Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.', EUR J CANCER, vol. 43, no. 7, 7, pp. 1180-1187. <http://www.ncbi.nlm.nih.gov/pubmed/17292604?dopt=Citation>

APA

Hutterer, G., Perrotte, P., Gallina, A., Walz, J., Jeldres, C., Traumann, M., Suardi, N., Saad, F., Bénard, F., Valiquette, L., McCormack, M., Graefen, M., Montorsi, F., & Karakiewicz, P. I. (2007). Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. EUR J CANCER, 43(7), 1180-1187. [7]. http://www.ncbi.nlm.nih.gov/pubmed/17292604?dopt=Citation

Vancouver

Hutterer G, Perrotte P, Gallina A, Walz J, Jeldres C, Traumann M et al. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. EUR J CANCER. 2007;43(7):1180-1187. 7.

Bibtex

@article{7431e0f8b2b54fcba902e527e4b37efc,
title = "Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.",
abstract = "OBJECTIVES: Body mass index (BMI) may alter serum prostate specific antigen (PSA) and percent free PSA (%fPSA) and may mask the risk of prostate cancer. We investigated the relationship between BMI and PSA or %fPSA. MATERIALS AND METHODS: Height, weight, PSA and %fPSA were assessed in 616 consecutive screened men without prostate cancer. Continuously coded and categorised BMI was studied. Statistical analyses consisted of ANOVA, linear regression, bivariate and partial correlations. RESULTS: Median age was 57 years. Median PSA was 1.0 and median %fPSA was 26. Median BMI was 25.8 kg/m(2). Neither continuously coded nor categorised BMI correlated with either PSA or %fPSA in unadjusted or age-adjusted analyses (all p values > or = 0.3). CONCLUSIONS: Body mass index does not affect PSA or %fPSA in men without known prostate cancer, who undergo prostate cancer screening. Therefore, PSA or %fPSA-based screening or early detection efforts do not require an adjustment for BMI.",
author = "Georg Hutterer and Paul Perrotte and Andrea Gallina and Jochen Walz and Claudio Jeldres and Miriam Traumann and Nazareno Suardi and Fred Saad and Fran{\c c}ois B{\'e}nard and Luc Valiquette and Michael McCormack and Markus Graefen and Francesco Montorsi and Karakiewicz, {Pierre I}",
year = "2007",
language = "Deutsch",
volume = "43",
pages = "1180--1187",
journal = "EUR J CANCER",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "7",

}

RIS

TY - JOUR

T1 - Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

AU - Hutterer, Georg

AU - Perrotte, Paul

AU - Gallina, Andrea

AU - Walz, Jochen

AU - Jeldres, Claudio

AU - Traumann, Miriam

AU - Suardi, Nazareno

AU - Saad, Fred

AU - Bénard, François

AU - Valiquette, Luc

AU - McCormack, Michael

AU - Graefen, Markus

AU - Montorsi, Francesco

AU - Karakiewicz, Pierre I

PY - 2007

Y1 - 2007

N2 - OBJECTIVES: Body mass index (BMI) may alter serum prostate specific antigen (PSA) and percent free PSA (%fPSA) and may mask the risk of prostate cancer. We investigated the relationship between BMI and PSA or %fPSA. MATERIALS AND METHODS: Height, weight, PSA and %fPSA were assessed in 616 consecutive screened men without prostate cancer. Continuously coded and categorised BMI was studied. Statistical analyses consisted of ANOVA, linear regression, bivariate and partial correlations. RESULTS: Median age was 57 years. Median PSA was 1.0 and median %fPSA was 26. Median BMI was 25.8 kg/m(2). Neither continuously coded nor categorised BMI correlated with either PSA or %fPSA in unadjusted or age-adjusted analyses (all p values > or = 0.3). CONCLUSIONS: Body mass index does not affect PSA or %fPSA in men without known prostate cancer, who undergo prostate cancer screening. Therefore, PSA or %fPSA-based screening or early detection efforts do not require an adjustment for BMI.

AB - OBJECTIVES: Body mass index (BMI) may alter serum prostate specific antigen (PSA) and percent free PSA (%fPSA) and may mask the risk of prostate cancer. We investigated the relationship between BMI and PSA or %fPSA. MATERIALS AND METHODS: Height, weight, PSA and %fPSA were assessed in 616 consecutive screened men without prostate cancer. Continuously coded and categorised BMI was studied. Statistical analyses consisted of ANOVA, linear regression, bivariate and partial correlations. RESULTS: Median age was 57 years. Median PSA was 1.0 and median %fPSA was 26. Median BMI was 25.8 kg/m(2). Neither continuously coded nor categorised BMI correlated with either PSA or %fPSA in unadjusted or age-adjusted analyses (all p values > or = 0.3). CONCLUSIONS: Body mass index does not affect PSA or %fPSA in men without known prostate cancer, who undergo prostate cancer screening. Therefore, PSA or %fPSA-based screening or early detection efforts do not require an adjustment for BMI.

M3 - SCORING: Zeitschriftenaufsatz

VL - 43

SP - 1180

EP - 1187

JO - EUR J CANCER

JF - EUR J CANCER

SN - 0959-8049

IS - 7

M1 - 7

ER -